Job Watch
Novo Nordisk: Research Scientist in Longitudinal Patient Data
Competitive Salary:
Novo Nordisk:
Would you like to leverage your bioinformatics- and data science skills to identify new drug targets for cardiometabolic disease...
Oxford
Categories: Job Watch
Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
Notice NOT-HG-21-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Reminder to AHRQ Grantees that FY2016 Funds will Expire on September 30, 2021
Notice NOT-HS-21-003 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Senior Technical Program Manager - Analysis Pipeline - Resolution Bioscience - Kirkland, WA
You will oversee the timely delivery of our cloud-based genomics analysis pipelines, working with bioinformatics scientists and software engineers.
From Resolution Bioscience - Thu, 03 Dec 2020 03:17:12 GMT - View all Kirkland, WA jobs
From Resolution Bioscience - Thu, 03 Dec 2020 03:17:12 GMT - View all Kirkland, WA jobs
Categories: Job Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development
Notice NOT-HG-21-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
Notice NOT-HG-21-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development
Notice NOT-HG-21-016 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: CeMM International PhD Program in Molecular Technologies and Systems Medicine
Fully funded position with competitive salary:
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences:
The next PhD Program at CeMM Research Center for Molecular Medicine in Vienna will start in October 2018. We offer 15 fully funded PhD positions
Vienna (AT)
Categories: Job Watch
Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation
Notice NOT-DK-21-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDDK Participation in PAR-20-238, Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Notice NOT-DK-21-006 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
EMBL: Linux Support Officer
Competitive Salary:
EMBL:
Linux Support Officer
Location:
Cambridge, Cambridgeshire, England
Categories: Job Watch
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U24 resource-related research projects. These revision applications can request support for expansion of the original scope of the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.
Categories: Job Watch, Literature Watch
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
Funding Opportunity RFA-CA-21-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. These revision applications can request support for expansion of the original scope of the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.
Categories: Job Watch, Literature Watch
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
Funding Opportunity RFA-CA-21-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.
Categories: Job Watch, Literature Watch
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described.
Categories: Job Watch, Literature Watch
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-015 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult the companion FOAs listed above.
Categories: Job Watch, Literature Watch
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-014 from the NIH Guide for Grants and Contracts. The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive. The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.
Categories: Job Watch, Literature Watch
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-013 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field. Potential applicants who are interested in downstream technology development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.
Categories: Job Watch, Literature Watch
NICHD Data and Safety Monitoring Guidelines for Extramural Clinical Trials and Clinical Research
Notice NOT-HD-20-036 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NICHD Participation on PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"
Notice NOT-HD-20-042 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Pages
